Story Landis | |
---|---|
Alma mater | Wellesley College, Harvard University |
Scientific career | |
Institutions | Harvard Medical School Case Western Reserve University School of Medicine National Institutes of Health |
Story Landis is an American neurobiologist and former director of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health. She was director of the institute between September 1, 2003 and October 2014. Dr. Landis worked at NINDS since 1995, and was named Chair of the NIH Stem Cell Task Force in 2007. [1]
She received her undergraduate degree in biology from Wellesley College in 1967 and her Master's Degree and Ph.D. from Harvard University. Her doctoral work at Harvard focused on cerebellar development in mice. She was a postdoctoral fellow at Harvard, where she studied transmitter plasticity in sympathetic neurons. [2]
Dr. Landis served as a professor in the Department of Neurobiology at Harvard Medical School until 1985, when she joined the faculty of Case Western Reserve University School of Medicine. [2]
She is an elected fellow of the American Academy of Arts and Sciences, the American Association for the Advancement of Science, and the American Neurological Association. [2]
The National Institute of Neurological Disorders and Stroke (NINDS) is a part of the U.S. National Institutes of Health (NIH). It conducts and funds research on brain and nervous system disorders and has a budget of just over US$2.03 billion. The mission of NINDS is "to reduce the burden of neurological disease—a burden borne by every age group, every segment of society, and people all over the world". NINDS has established two major branches for research: an extramural branch that funds studies outside the NIH, and an intramural branch that funds research inside the NIH. Most of NINDS' budget goes to fund extramural research. NINDS' basic science research focuses on studies of the fundamental biology of the brain and nervous system, genetics, neurodegeneration, learning and memory, motor control, brain repair, and synapses. NINDS also funds clinical research related to diseases and disorders of the brain and nervous system, e.g. AIDS, Alzheimer's disease, epilepsy, muscular dystrophy, multiple sclerosis, Parkinson's disease, spinal cord injury, stroke, and traumatic brain injury.
Eva Lucille Feldman, M.D., Ph.D., F.A.A.N., F.A.N.A. is an American physician-scientist and one of the world’s leading authorities on neurodegenerative disease. Currently, she serves as the Russell N. DeJong Professor of Neurology at the University of Michigan, as well as Director of the NeuroNetwork for Emerging Therapies and ALS Center of Excellence at Michigan Medicine.
Cato T. Laurencin, M.D., Ph.D., is an American engineer, physician, scientist, innovator and a University Professor of the University of Connecticut.
Ruth Lillian Kirschstein was an American pathologist and science administrator at the National Institutes of Health (NIH). Kirschstein served as director of the National Institute of General Medical Sciences, deputy director of NIH in the 1990s, and acting director of the NIH in 1993 and 2000-2002.
Norman Bruce Anderson is an American scientist who was a tenured professor studying health disparities and mind/body health, and later an executive in government, non-profit, university sectors. Anderson is assistant vice president for research and academic affairs, and research professor of social work and nursing at Florida State University. He previously served as chief executive officer of the American Psychological Association (APA), the largest scientific and professional association for psychologists in the United States. Anderson became the APA's first African-American CEO when he was named to the post in 2003. He was the editor for the APA journal American Psychologist. Prior to joining APA, Anderson was an associate director of the National Institutes of Health (NIH) and held other roles in academia.
Jeffrey Paul Sutton is a Canadian-American physician-scientist who holds the Friedkin Chair for Research in Sensory System Integration and Space Medicine at Baylor College of Medicine (BCM), where he is the founding Director and Professor in the Center for Space Medicine. He is also Chairman of the Board of the Translational Research Institute for Space Health that is part of the Human Research Program of the National Aeronautics and Space Administration. Sutton is the former Chief Executive Officer, President and Institute Director of the National Space Biomedical Research Institute.
Leona D. Samson is the Uncas and Helen Whitaker Professor and American Cancer Society Research Professor of Biological Engineering at the Massachusetts Institute of Technology, where she served as the Director of the Center for Environmental Health Sciences from 2001 to 2012. Before her professorship at MIT, she held a professorship at the Harvard School of Public Health. She is on the editorial board of the journal DNA Repair. Her research interests focus on "methods for measuring DNA repair capacity (DRC) in human cells", research the National Institute of Health recognized as pioneering in her field, for which the NIH granted her the National Institutes of Health Director's Pioneer Award.
Patricia A. Grady is an American neuroscientist internationally recognized for her research on stroke, which specializes in cerebral blood flow, metabolism, and function. She is director of the National Institute of Nursing Research (NINR), part of the National Institutes of Health (NIH) in Bethesda, Maryland. Grady was elected to the Institute of Medicine in 1999 and is a member of several scientific organizations, including the Society for Neuroscience and the American Academy of Nursing. She is a fellow of the American Stroke Association and the American Neurological Association.
Joan Y. Reede is an American physician. She is Harvard Medical School's inaugural dean for diversity and community partnership, and a member of the National Academy of Medicine. She is known for creating programs that mentor and support minority physicians and female physicians. Alumni of her programs have created a 501(c)(3) organization called The Reede Scholars in her honor.
Elaine Ann Ostrander is an American geneticist at the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH) in Bethesda, Maryland. She holds a number of professional academic appointments, currently serving as Distinguished and Senior Investigator and head of the NHGRI Section of Comparative Genomics; and Chief of the Cancer Genetics and Comparative Genomics Branch. She is known for her research on prostate cancer susceptibility in humans and for conducting genetic investigations with the Canis familiaris —the domestic dog— model, which she has used to study disease susceptibility and frequency and other aspects of natural variation across mammals. In 2007, her laboratory showed that much of the variation in body size of domestic dogs is due to sequence changes in a single gene encoding a growth-promoting protein.
Martha Vaughan was an American biochemist at the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH) in Bethesda, Maryland. She holds the title of emeritus scientist in the Laboratory of Metabolic Regulation and previously served as chief of NHLBI’s Laboratory of Cellular Metabolism. At the NIH, much of her work has focused on cell signaling, cellular regulation, lipid metabolism, and the identification of key proteins associated with cholera toxin and pertussis toxin. Vaughan first came to the NIH in the agency’s fledgling National Heart Institute, now NHLBI, and with the title of senior assistant surgeon worked on protein synthesis in the Building 3 laboratory of biochemist and public scientist Christian B. Anfinsen, Ph.D., who went on to share the 1972 Nobel Prize in Chemistry
Phyllis C. Zee is the Benjamin and Virginia T. Boshes Professor in Neurology, the director of the Center for Circadian and Sleep Medicine (CCSM) and the chief of the Division of Sleep Medicine (neurology) at the Feinberg School of Medicine, Northwestern University, Chicago. She is also the medical director of Sleep Disorders Center at Northwestern Memorial Hospital.
Martha Gray is a biomedical engineer and professor at the Massachusetts Institute of Technology, jointly appointed in the Department of Electrical Engineering and Health Sciences and Technology (HST). Gray became the first woman to lead a department of science or engineering at MIT when she became the co-director of the Harvard–MIT Program of Health Sciences and Technology in 1987. She has developed multidisciplinary programs at MIT. Her research focuses on understanding and preventing Osteoarthritis, and her team developed the imaging technology dGEMRIC, now used to examine cartilage.
Susan S. Ellenberg is an American statistician specializing in the design of clinical trials and in the safety of medical products. She is a professor of biostatistics, medical ethics and health policy in the Perelman School of Medicine at the University of Pennsylvania. She was the 1993 president of the Society for Clinical Trials and the 1999 President of the Eastern North American Region of the International Biometric Society.
Daniel Alfonso Colón-Ramos is the McConnell Duberg Professor of Neuroscience and Cell Biology at Yale University School of Medicine, where his lab studies the cell biology of the synapse during development and learning. He is also the founder of the nonprofit organization Ciencia Puerto Rico (CienciaPR), a collaborative network for people interested in science and Puerto Rico. In 2020, he was named to the National Academy of Medicine.
Camara Phyllis Jones is an American physician, epidemiologist, and anti-racism activist who specializes in the effects of racism and social inequalities on health. She is known for her work in defining institutional racism, personally mediated racism, and internalized racism in the context of modern U.S. race relations. During the COVID-19 pandemic, Jones drew attention to why racism and not race is a risk factor and called for actions to address structural racism.
Karla Kirkegaard is the Violetta L. Horton Research Professor of genetics at the Stanford University School of Medicine. She was the chair of the Department of Microbiology and Immunology from 2006 to 2010. She is an elected member of the American Academy of Arts and Sciences and the National Academy of Sciences. Her research focuses on virology.
HollisT. Cline is the Hahn Professor of Neuroscience, Chair of the Neuroscience Department and Director of the Dorris Neuroscience Center at the Scripps Research Institute in California. She is a Fellow of the American Association for the Advancement of Science and was awarded the Society for Neuroscience Mika Salpeter Lifetime Achievement Award in 2019. Cline is known for her studies of how sensory experience affects brain development and plasticity. She was elected a member of the National Academy of Sciences in 2022.
Amanda Brown is an American immunologist and microbiologist as well as an associate professor of neurology and neuroscience at Johns Hopkins University School of Medicine in Baltimore, Maryland. Brown is notable for cloning one of the first recombinant HIV viruses and developing a novel method to visualize HIV infected cells using GFP fluorescence.
Judith Ann Cooper is an American speech pathologist serving as the deputy director of the National Institute on Deafness and Other Communication Disorders (NIDCD). She was the acting director of the NIDCD from June 2018 to August 2019. Cooper is an elected fellow of the American Speech–Language–Hearing Association.